Literature DB >> 28656895

WHO R&D Blueprint: a global coordination mechanism for R&D preparedness.

Marie Paule Kieny1, Peter Salama2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28656895     DOI： 10.1016/S0140-6736(17)31635-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

Review 1.  Design of vaccine efficacy trials during public health emergencies.

Authors:  Natalie E Dean; Pierre-Stéphane Gsell; Ron Brookmeyer; Victor De Gruttola; Christl A Donnelly; M Elizabeth Halloran; Momodou Jasseh; Martha Nason; Ximena Riveros; Conall H Watson; Ana Maria Henao-Restrepo; Ira M Longini
Journal:  Sci Transl Med       Date:  2019-07-03       Impact factor: 17.956

2.  Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo.

Authors:  Carl A B Pearson; W John Edmunds; Thomas J Hladish; Rosalind M Eggo
Journal:  Int J Epidemiol       Date:  2022-02-18       Impact factor: 7.196

3.  DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR.

Authors:  Natalie E Dean; M Elizabeth Halloran; Ira M Longini
Journal:  Ann Appl Stat       Date:  2018-03-09       Impact factor: 2.083

4.  Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.

Authors:  Louise Sigfrid; Katherine Maskell; Peter G Bannister; Sharif A Ismail; Shelui Collinson; Sadie Regmi; Claire Blackmore; Eli Harriss; Kajsa-Stina Longuere; Nina Gobat; Peter Horby; Mike Clarke; Gail Carson
Journal:  BMC Med       Date:  2020-06-25       Impact factor: 8.775

Review 5.  So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.

Authors:  Christine Grady; Seema Shah; Franklin Miller; Marion Danis; Marie Nicolini; Jorge Ochoa; Holly Taylor; Dave Wendler; Annette Rid
Journal:  Vaccine       Date:  2020-08-11       Impact factor: 3.641

6.  Global vaccine action plan lessons learned I: Recommendations for the next decade.

Authors:  Noni MacDonald; Ezzeddine Mohsni; Yagob Al-Mazrou; Jon Kim Andrus; Narendra Arora; Susan Elden; Marie-Yvette Madrid; Rebecca Martin; Amani Mahmoud Mustafa; Helen Rees; David Salisbury; Qinjian Zhao; Ian Jones; Christoph A Steffen; Joachim Hombach; Katherine L O'Brien; Alejandro Cravioto
Journal:  Vaccine       Date:  2020-05-05       Impact factor: 3.641

7.  Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.

Authors:  Natalie E Dean; Pierre-Stéphane Gsell; Ron Brookmeyer; Forrest W Crawford; Christl A Donnelly; Susan S Ellenberg; Thomas R Fleming; M Elizabeth Halloran; Peter Horby; Thomas Jaki; Philip R Krause; Ira M Longini; Sabue Mulangu; Jean-Jacques Muyembe-Tamfum; Martha C Nason; Peter G Smith; Rui Wang; Ana M Henao-Restrepo; Victor De Gruttola
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 176.079

8.  Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico.

Authors:  Donal Bisanzio; Felipe Dzul-Manzanilla; Hector Gomez-Dantés; Norma Pavia-Ruz; Thomas J Hladish; Audrey Lenhart; Jorge Palacio-Vargas; Jesus F González Roldan; Fabian Correa-Morales; Gustavo Sánchez-Tejeda; Pablo Kuri Morales; Pablo Manrique-Saide; Ira M Longini; M Elizabeth Halloran; Gonzalo M Vazquez-Prokopec
Journal:  PLoS Negl Trop Dis       Date:  2018-03-15

9.  Lessons learned from Ebola Vaccine R&D during a public health emergency.

Authors:  Marie-Paule Kieny
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

10.  Biochemical and structural studies reveal differences and commonalities among cap-snatching endonucleases from segmented negative-strand RNA viruses.

Authors:  Tobias Holm; Janine-Denise Kopicki; Carola Busch; Silke Olschewski; Maria Rosenthal; Charlotte Uetrecht; Stephan Günther; Sophia Reindl
Journal:  J Biol Chem       Date:  2018-10-22       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.